Eighteen hospitalized male diabetic patients, thirty to sixty-nine years of age, were studied. The known duration of the diabetes in the group ranged from one to twenty-five years. All patients ...
A lab-designed protein mimicking both insulin and glucagon has shown promising results for controlling blood sugar in Type 1 diabetes The formulation may not require ...
Researchers at the Indiana University School of Medicine have discovered a new way to regulate blood glucose levels using a lab-designed protein, possibly opening the door to a new treatment avenue ...
Glucagon raises the blood glucose concentration by mobilizing hepatic glycogen stores through activation of liver phosphorylase. Because crystalline glucagon is rapidly inactivated once it enters the ...
Beta cells play a key role in the pathogenesis of both Type 1 and Type 2 diabetes. However, pancreatic islets also have alpha cells that produce the hormone glucagon, which acts to raise glucose blood ...
Patients with type 2 diabetes secrete not only too little insulin but also too much glucagon, which contributes to poor blood glucose control. A new study from Uppsala University suggests that this is ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio People with type 1 diabetes can be safely ...
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the availability in the United States of its Glucagon Emergency Kit, an FDA-approved and cost-effective alternative to treat severe ...
The US Food and Drug Administration (FDA) has approved a prefilled glucagon rescue pen (Gvoke HypoPen, Xeris Pharmaceuticals) for the treatment of severe hypoglycemia in adult and pediatric patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback